K623-0510 Screening compound: 3-[(3,5-dimethoxybenzoyl)amino]-N~1~-(2-methoxyethyl)-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide

K623-0510 Screening compound: 3-[(3,5-dimethoxybenzoyl)amino]-N~1~-(2-methoxyethyl)-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide
K623-0510 Screening compound: 3-[(3,5-dimethoxybenzoyl)amino]-N~1~-(2-methoxyethyl)-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K623-0510
3-[(3,5-dimethoxybenzoyl)amino]-N~1~-(2-methoxyethyl)-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K623-0510

Molecular Formula

C30H34N4O6 (C30 H34 N4 O6)

Compound Name

3-[(3,5-dimethoxybenzoyl)amino]-N~1~-(2-methoxyethyl)-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide

IUPAC name

3-(35-dimethoxybenzamido)-N-(2-methoxyethyl)-4-{6-oxo-711-diazatricyclo[7.3.1.0^{27}]trideca-24-dien-11-yl}benzamide

SMILES

COCCNC(c(cc1)cc(NC(c2cc(OC)cc(OC)c2)=O)c1N(CC(C1)CN23)CC1C3=CC=CC2=O)=O

InChI

InChI=1S/C30H34N4O6/c1-38-10-9-31-29(36)20-7-8-27(25(14-20)32-30(37)21-12-23(39-2)15-24(13-21)40-3)33-16-19-11-22(18-33)26-5-4-6-28(35)34(26)17-19/h4-8,12-15,19,22H,9-11,16-18H2,1-3H3,(H,31,36)(H,32,37)

InChI Key

ZEWXXHRGZPMWLL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02657097

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

546.62

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.667

Distribution Coefficient, logD

3.654

Water Solubility, LogSw

-4.10

Polar Surface Area

89.439

Acid Dissociation Constant (pKa)

8.93

Base Dissociation Constant (pKb)

-0.11

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

36.70

K623-0510 in Drug Discovery

Included in Screening Libraries

Dark Chemical Matter Library (18430 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Structure:
  • Pool
  • Cyclic compounds
  • Cyclic compounds
Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with K623-0510 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K623-0510?
Check Price and Availability of K623-0510, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K623-0510 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K623-0510
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K623-0510
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K623-0510 available by request